Schedule 13G ownership disclosure
ZIOPHARM ONCOLOGY INC
Security class unavailable · CUSIP: 98973P101
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 16,254,127
- Percent of class
- 7.4500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-21-000853
- Form type
- SC 13G
- Filer
- MILLER VALUE PARTNERS, LLC
- CIK
- CIK 1135778
- Filed
- Feb 16, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership